Raymond James Financial’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
USCWA
NA
SPIA
RA
WIA
FIB
Raymond James Financial's REVS Position: Q1 2026 in Review
Raymond James Financial increased its Columbia Research Enhanced Value ETF (REVS) stake by 112% in Q1 2026, buying an estimated $8.86M and bringing the position to 575,714 shares worth $16.5M. The position accounts for 0.01% of the portfolio, ranked #1613.
Raymond James Financial first reported a position in REVS in Q4 2024 and has held it in 6 quarters since. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.
- Raymond James Financial held 575,714 shares of Columbia Research Enhanced Value ETF worth $16.5M as of Q1 2026.
- Raymond James Financial bought 304,157 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $8.86M.
- Columbia Research Enhanced Value ETF made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1613 holding.
- Raymond James Financial first reported a position in Columbia Research Enhanced Value ETF in Q4 2024 and has held it in 6 quarters since.
- 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.
Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.